Ryan Lynch
CIK: 0001709271
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CBIO
CRESCENT BIOPHARMA, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
Sale(S)Direct240 shares at avg. $17.90$4K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
Sale(S)Direct465 shares at avg. $17.99$8K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
Award(A)Direct8.4K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
Award(A)Direct4K shares-
1-4 of 4 transactions
About Lynch Ryan
Lynch Ryan (SEC CIK 0001709271) files insider reports with the SEC as Officer of CRESCENT BIOPHARMA, INC. (CBIO).
Signal8 holds 4 ownership filings by Lynch Ryan (1 Form 3, 3 Form 4), filed between Jun 23, 2025 and Sep 18, 2026. Those filings report 4 transactions, from Dec 15, 2025 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lynch Ryan's filings is in WALTHAM, MA.
Recent filings by Lynch Ryan
Other insiders filing for CRESCENT BIOPHARMA, INC. (CBIO)
- Pinkas Jan, Chief Scientific Officer
- Im Ellie Eunkyung, Chief Medical Officer
- Scalzo Richard William, Chief Financial Officer
- Bispham Barbara Harlin
- Brumm Joshua T, Chief Executive Officer
- McNeill Jonathan, President and COO